Clinical Tools for Prenatal Providers

Identify Best Practices for TestingĀ and Diagnosis of GDM and T2DM

Clinical tools were developed with direction from a clinical advisory panel and contain guidance on best practices for testing and diagnosing your consumers with GDM and T2DM.

Download the Gestational Diabetes Change Package

Family Toolkit
Patient Resources

Patient Resources Includes:

  • Impact of GDM on both mother and babies health
  • Recommended lifestyle changes, included exercises that pregnant moms can do
  • Nutrition guidelines and best choices for food to maintain recommended blood sugar when pregnant
  • Benefits of breastfeeding for mom and baby
  • Identifying and treating baby blues
  • Talking to your healthcare providers about your risk for Type 2 Diabetes and how to get tested by 12 weeks postpartum


Download in Spanish

Download in Arabic

Download in Somali

Download in French

Provider Resources

Provider Resources Include:

  • Testing and diagnostic criteria
  • Care coordination strategies and resources
  • Health and wellness educational messaging for consumers
  • Best practice flowchart for an office-based setting
  • Shared decision making guides


Timely Testing For GDM

There are select groups of women including African American, American Indian or Alaska Native, Asian American, Hispanic or Latino, and Native Hawaiian or Pacific Islanders that are at greater risk for being diagnosed with GDM. Early identification can greatly improve the birth outcomes for these women. Additionally, consumers that meet the below criteria should also receive their OGTT early in pregnancy:

  • Diagnosed with GDM during a prior pregnancy
  • Known impaired glucose metabolism
  • Gave birth to a baby weighing more than 9 lbs
  • Obesity with BMI greater than 30
  • Polycycstic ovarian syndrome

Patients who don't meet one or more of these defined criteria should receive their OGTT test between 24 and 28 6/7 weeks gestation.

Postpartum Testing for T2DM

ACOG currently recommends providing an OGTT test between 4-12 weeks postpartum to identify patients' risk for Type 2 Diabetes. Scheduling the test either prior to delivery or while the consumer is in the hospital immediately following, may increase the likelihood of receipt of the test. If the consumer tests negative for T2DM, she should follow up subsequently every three years to test her risk for it in the future. If upon receipt of the test she is identified as being pre-diabetic that test should occur annually. However, if she tests positive for T2DM, she should establish regular appointments with a Primary Care Provider (PCP) and participate in self-management education and connect with a Dietician and/or Diabetes Educator to establish a care plan moving forward. Coordinating care among OBGYNs, PCPs, and Diabetes professionals is essential to ensure all future pregnancies are healthy and your consumer's condition is properly monitored.

Our Partners